Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated just now
Peer-reviewedLicence not statedAnnals of the Rheumatic Diseases

2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19

12 more authors

Related

  1. EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19
    Alessia Alunno, Aurélie Najm, Pedro Machado +21
    Annals of the Rheumatic DiseasesPeer-reviewedCC BY-NCFull text41 citedImmunologyGeneral medicineHAL
  2. EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update
    Bernhard Hellmich, Beatriz Sanchez-Alamo, Jan Schirmer +24
    Annals of the Rheumatic DiseasesPeer-reviewedLicence not statedFull text906 citedImmunologyGeneral medicineHAL
  3. Points to consider for the reporting of variants of uncertain significance in germline genetic and genomic testing: A statement of the American College of Medical Genetics and Genomics (ACMG)
    Chloe E. Mighton, Aya Abu‐El‐Haija, Vimla Aggarwal +13
    Genetics in MedicinePeer-reviewedLicence not statedFull text20 citedGenetics & genomicsOpenAlex
  4. EULAR recommendations for physical activity in people with inflammatory arthritis and osteoarthritis: 2025 update
    Anne-Kathrin Rausch Osthoff, Theodora Vlieland, Ricardo Ferreira +23
    Annals of the Rheumatic DiseasesPeer-reviewedCC BYFull text14 citedGeneral biologyEpidemiology & public healthHAL
  5. Immunomodulatory and targeted therapies for metastatic colorectal cancer
    Kuiliang Gao, Qianqian Lv, Lidan Zhao +1
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0ImmunologyCrossref
BibTeX
@article{alunno20262021,
  title = {{2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19}},
  author = {Alessia Alunno and Aurélie Najm and Pedro Machado and Heidi Bertheussen and Gerd-Rüdiger Burmester and Francesco Carubbi and Gabriele de Marco and Roberto Giacomelli and Olivier Hermine and John Isaacs and Isabelle Koné-Paut and César Magro-Checa and Iain Mcinnes and Pier Luigi Meroni and Luca Quartuccio and A Ramanan and Manuel Ramos-Casals and Javier Rodríguez Carrio and Hendrik Schulze-Koops and Tanja Stamm and Sander Tas and Benjamin Terrier and Dennis Mcgonagle and Xavier Mariette},
  journal = {Annals of the Rheumatic Diseases},
  year = {2026},
  month = nov,
  doi = {10.1136/annrheumdis-2021-221366},
  url = {https://hal.science/hal-05865032v1},
}
RIS
TY  - JOUR
TI  - 2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19
AU  - Alessia Alunno
AU  - Aurélie Najm
AU  - Pedro Machado
AU  - Heidi Bertheussen
AU  - Gerd-Rüdiger Burmester
AU  - Francesco Carubbi
AU  - Gabriele de Marco
AU  - Roberto Giacomelli
AU  - Olivier Hermine
AU  - John Isaacs
AU  - Isabelle Koné-Paut
AU  - César Magro-Checa
AU  - Iain Mcinnes
AU  - Pier Luigi Meroni
AU  - Luca Quartuccio
AU  - A Ramanan
AU  - Manuel Ramos-Casals
AU  - Javier Rodríguez Carrio
AU  - Hendrik Schulze-Koops
AU  - Tanja Stamm
AU  - Sander Tas
AU  - Benjamin Terrier
AU  - Dennis Mcgonagle
AU  - Xavier Mariette
PY  - 2026
DA  - 2026/11/15
JO  - Annals of the Rheumatic Diseases
DO  - 10.1136/annrheumdis-2021-221366
UR  - https://hal.science/hal-05865032v1
SN  - 0003-4967
SN  - 1468-2060
ER  -